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Antiserum raised in rabbits against the Triton X-I 00 insolu-
ble fraction of melanosomes from mouse melanoma cells 
specifically decorates the internal matrix of melanosomes in 
immunoelectron microscopy. In metabolic labeling studies, 
the antiserum recognizes a protein of 94 kDa, which is pro-
cessed to a band of 53 kDa. Whereas the precursor is rela-
tively soluble in buffers containing Triton X-IOO, the pro-
cessed protein requires the addition of sodium dodecyl sulfate 
for effective solubilization, as would be expected for a mela-
nosomalmatrix constituent. Tunicamycin reduces the Mr of 
the nascent protein to 75 kDa, but deoxymannojirimycin and 
swainsonine have no effect, suggesting that following initial 
glycosylation in the endoplasmic reticulum, the protein is 
T he melanosome is the site of melanin syntheS.is and deposition in melanocytes. E lectron microscopy re-vea ls that the melanosome is an elliptical, membrane-bounded organelle containing a filamentous matrix upon which insoluble melanin is deposited [1] . 
Five proteins, all studied at the mol ecular level, have been shown 
to be or are suspected to be loca lized to the melanosomal membrane: 
tyrosinase [2,3], tyrosinase-related protein (TRP)-1 [2,3]' tyrosin-
ase-related protein-2 (dopachrome tautomerase) [2] , Pmel 17 [4], 
and the product of the pink-eyed dilution locus [5 ,6]. The first three 
of these are known to be soluble in non-ionic detergents; the solubi-
lities of the latter two have not yet been reported. 
In contrast, littl e is known about the individual constituents of 
the melanosomal matrix. Treatment of melanosomes with non-
ionic detergents, such as Triton X-I 00, strips the melanosome of its 
membrane, solubilizes tyrosinase and other melanogenic enzymes, 
but leaves the matrix relatively intact [7 -1 0]. Harsher treatments, 
including the use of sodium dodecyl sulfate (SDS), urea, or strong 
bases, are required to disrupt the melanized melanosomal matrix [8]. 
A monoclona l antibody, HMSA-l, is reported to recognize the mel-
anosomal matrix in melanoma cells, but fails to recognize an antigen 
in normal melanocytes, which also contain melanosomal matrix 
[11]. A melanosomal matrix protein of MW 115,000 that shares 
seq uence homology with that of Pmel 17 has been identified in 
chicken retinal pigmented epithelium [12], but whether it is present 
in neural-crest- der ived melanocytes of the eye and skin in chickens 
or in mammals is not known. 
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not subject to processing by glycosidases in the Golgi appa-
ratus or may bypass it entirely. Subcellular fractionation fol-
lowed by immunoblotting confirms that the protein is 
present in the melanosome-rich, large granule fraction. Ex-
pression of the protein is regulated differently from that of 
the tyrosinase-related protein family . Conditions that greatly 
stimulate expression of tyrosinase-related proteins do not af-
fect matrix protein expression, nor is the protein immuno-
logically related to the tyrosinase-related protein family. Our 
results suggest that we have identified an authentic compo-
nent of the mammalian melanosomal matrix, and that its 
characteristics lend support to a bipartite pathway for mel a-
nosomal biogenesis. ] Invest Dermatol1 01 :141-144, 1993 
We report on the identification of a g lycoprotein by immuno-
logic methods that fulfills the biochemical and cellular criteria for 
an authentic component of the melanosomal matrix, and discuss the 
implication of the characteristics of this prote in for the biogenesis of 
melanosomes. 
MATERIALS AND METHODS 
Cell Lines B16 cells were grown as previously described [13]. Cultured 
melanocytes from C57BL/6J mice (melan-a cells) were obtained from Dr. 
D. Bennett via Dr. V. Hearing (National Cancer Institute) and cul tured as 
described [14]. Tumors from B 16 ce lls were raised by subcutaneous injection 
of 1 X 106 cells into C57BL/6J mice. Tumors were harvested prior to 
reaching 5% of total body weight. 
Preparation of Anti-Melanosomal Matrix Antiserum Mclanosomes 
were purified from B16 tumors as described previously [1 5].ln brief, tumors 
were dissected free of connective tissue, homogenized with a glass to glass 
homogenizer; a large granule fraction was prepared and then subjected to 
discontinuous sucrose density centrifugation. The dense, black melanosomal 
band was resuspended and pelleted by centrifugation at 10,000 X g for 30 
min. The melanosomal pellet was extracted by incubation on ice with 1 % 
Triton X-lOO in 0.1 M sodium phosphate buffer pH 6.S, fo llowed by two 
extractions with the same buffer containing 0.4 M NaCI. The insoluble 
pellet (matrix) was resuspended in 1 % SDS, and 200 JLg were injected subcu-
taneously in Freund's complete adjuvant in a New Zealand white rabbit. The 
rabbit was boosted monthly for 6 months using 200,ug of matrix protein in 
Freund's incomplete adjuvant. Blood was collected from the ear vein and 
allowed to clot, and serum was isolated by centrifugation. 
Immunologic Techniques Immunoprecipitation from metabolically 
labeled cells, immunoblotting with sequence-specific anti peptide antisera to 
tyrosinase and TRPs, and immunoelectron microscopy were performed as 
described previously [3,16]. For immunoblotting, antisera were used at the 
following dilutions: atyrosinase (aTYR) (aPEP7, 1 : 200), aTRP-l (aPEP 
1, 1: 500), aTRP-2 (aPEPS, 1: 500) (all obtained from Dr. V. Hearing, 
NCI), and antimclanosomal matrix (aMX) (1: 100). 
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Figure 1. lmmunoelectron microscopy using anti melanosomal matrix 
serum. B16 cells were immunostained with aMX at 1: 10,000 dilution 
followed by goat anti-rabbit IgG conjugated to 5 nm colloidal gold particles 
at 1 : 30. Two representative fields are shown (a,b). Bars, 0.5/1111. 
RESULTS 
ImmuDomicroscopy Immunofluorescence analysis of cultured 
B16 cells carried out with the aMX serum showed a granular pat-
tern, consistent with a melanosomal localization (not shown). Im-
munoelectron microscopy performed on the same cell line revealed 
that the antiserum specifically recognized the matrix of stage II and 
early stage III melanosomes (Fig la,b). The presence of large 
amounts of melanin in late stage III and IV melanosomes (Fig Ib) 
obscured any analysis of the labeling of matrix by antibody in these 
organelles. 
Antigens Recognized by the Antimatrix Serum Figure 2A 
demonstrates the protein pattern present in the melanosomal matrix 
preparation used to produce the aMX serum. The Triton-insoluble 
matrix contains bands of 94, 53, 46, and 35 - 36 kDa. 
The aMX serum was tested in immunoblotting experiments. 
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Figure 2. A, Mclanosomal matrix proteins. The l11elanosomal fraction of 
mouse melanoma cells was isolated, extracted, and subjected to SDS-polya-
crylamide gel electrophoresis (PAGE) and stained with Coomassie Brilliant 
Blue as described [3,14]. Lalle 1, whole melanosomes, (Iall e 2) the Triton 
X-I00 soluble portion of melanosomes, and (Iall e 3) the Triton-insoluble, 
salt-washed matrix fraction used as an immunogen. Note the presence of 
bands of94 (solid arrow) and 53 kDa (opell arrow) in lalle 3. The migration of 
markers of known Mr is shown in kilodaltons at the right. B, Antigens 
recognized by aMX serum. Twenty micrograms of a post-nuclear superna-
tant prepared from cultured B16 cells were subjected to SDS-PAGE. Im-
munoblotting with normal rabbit serum (left lalle) and aMX serum (rig/It 
lalle) was performed as described in Materials alld Methods. Two antigens are 
recognized: 94 kDa (solid arrow) and 53 kDa (ope II arrow). 
Analysis of homogenates of B16 cells induced to melanize by cul-
ture in synthetic AIM V medium [13] revealed that the antiserum 
recognized bands of94 and 53 kDa (Fig 2B), which corresponded to 
two of the major bands present in the purified matrix preparation. In 
normal cultured melanocytes (melan-a cells), the higher Mr band 
was more prevalent. 
Subcellular fractionation studies were performed to assess the 
distribution of the antigens. Both the 94-kDa and 53-kDa antigens 
were enriched in the large granule fraction (melanosome-rich 
10,000 X g pellet [17]) of both B 16 cells and mel an-a cells (Fig 3). 
Extraction of this pellet with 1 % Triton X-lOa resulted in solubili-
zation of the majority of the 94-kDa species, whereas the 53-kDa 
species remained p'redominantly in the Triton-insoluble pellet 
(compare Fig 3, lanes 3 and 4, aMX serum). In contrast, tyrosinase, 
TRP-l and TRP-2 also were highly enriched in the large granule 
fraction, but all cou ld be preferentially solubilized with Triton 
X-lOa (Fig 3, lalle 3). 
The regulation of expression of the matrix antigens also differed 
from that of the tyrosinase-related protein family. We have shown 
previously [13] that culture of B 16 cells in AIM V medium causes a 
10 to 50 times increase in melanization and in the expression of 
tyrosinase. The data in Fig 4 demonstrate similar induction of tyro-
sinase and TRP-2 expression as a result of culture in AIM V me-
dium. Similar results were obtained for TRP-l (data not shown). In 
contrast, levels of matrix antigen were high in unstimulated B1 6 
cells, and changed little following AIM V stimulation (Fig 4, open 
arrow). 
Biosynthetic Studies £16 cells were metabolically labeled with 
(35S]-labeled methionine/cysteine, extracted with buffer containing 
both Triton X-I 00 and 0.1 % SDS, and subjected to immunoprecip-
itation. After 15 min of labeling, only the 94-kDa species was evi-
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Figure 3. Subcellu lar fractionation and solubility of matrix antigens. B16 
melanoma cells and me lan-a cultured melanocytes were homogenized and a 
10,000 X g pellet (large granule fraction) prepared and extracted with Tri-
ton X-I 00 as described in Materials alld Methods. Eight micrograms of protein 
were applied to each lane and subjected to SOS-PAGE followed by immuno-
blotting with the antiserum indica ted on the left. The migration of markers 
of 97,69, and 46 kOa is shown on the right. The contents of each lane were 1 
who le cel l homogenate, 2 10,000 X g supernatant, 3 Triton X-I 00 soluble 
portion of the large granule fraction, and 4 Triton X-insoluble portion of the 
large granule fraction. 
dent (Fig SA). Inclusion of tunicamycin (which blocks the initial 
addi tion of asparagine-linked sugars in the endoplasmic reticu lum 
[18]) resulted in a decrease in Mr of the protein to 75 kDa, but no 
effect was seen on inclusion of swainsonine or deoxymannojirimy-
cin, two inhibitors of later stages of the processing of asparagine-
linked glycoproteins that occur in the Golgi apparatus [18) . Iflabel-
ing was carried out for 4 h, a small amount of the 53-kDa species 
appeared but the 94-kDa band still predominated (Fig 5B) . How-
ever, following an additional 4-h "chase" with unlabeled medium, 
the intensity of the 94-kDa band diminished and the 53-kDa band 
predominated, suggestin g a precursor - product relationship be-
tween these species (Fig 5B). !fSDS was not included in extraction 
buffers, the time course of appearance and disappearance of the 
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Figure 4. Diflerential regulation ofTRP and MX antigen expression. B16 
cel ls (Ialles 1) and B16 ce lls induced to heavily melanize by culture for 10 din 
AIM V medium [1 3] (Ialles 2) were homogenized and 8 JIg of protein were 
applied to each lane, and subjected to SOS-PAGE fo llowed by il11munoblot-
ting with the indicated antisera. Opell arrow, 53-kOa antigen; solid arrow, 
94-kOa band. 
94-kDa band was preserved, but the 53-kDa species was not ob-
served, which was in keeping w ith its Triton-insoluble nature (data 
not shown) . 
DISCUSSION 
Our results sugges t that we have identified an auth entic melano-
somal matrix protein. The protein is sy nt hesized as a Triton-soluble 
precursor of94 kDa, which is then processed over time, possibly by 
proteolysis, to a 53-kDa species. As expected for a mel anosomal 
matrix protein [8) , the processed protein is enriched in the large-
granule fraction and is relatively insoluble in non-ionic detergent, 
but can be solubilized by buffers containing SDS. 
From metabolic labeling studies, we conclude that the matrix 
protein is subject to asparagine-linked glycosyla tion , but that it is 
insensitive to inhibitors of later stages of o ligosaccharide modifica-
tion that occur in the Golgi apparatus [1 8). Thus, this protein either 
bypasses the Go lgi appara tus or lacks the appropriate sequence of 
sugar residues that are acted on by thc cnzym es inhibited by swain-
sonine and deoxymannojirimycill. It is interes ting that a number of 
schemes for melanosomal biogenesis derivcd largely from electron 
microscopy suggest that the pre-melanosome arises from the endo-
plas tuic reticulum or cis face of the Golgi apparatus directly bypass-
ing its mid and late saccul es [1 J, which is consistent with the glyco-
sylation pattern of the protein we have identified. In contrast, we 
and others have shown that tyrosinase and the tyrosinase- related 
proteins, which are believed to be shuttl ed in vesicles from trans-
Golgi network to the pre-melanosome, are subject to middle and 
late Golgi associated g lycoprotein modification [3,19 - 22). 
Immunomicroscopic analys is and subcellul ar fractionation con-
firm that the protein we have identified is localized to the melano-
somal matrix. The protein is present in both malignant and normal 
melanocytes cultured from C57B1/6 mice. Akutsu and Jimbow 
have described a monoclona l an tibody, HMSA-l , w hich is specific 
for malignant human melanocytes (melanoma) and docs not recog-
nize normal 111elanocytes [11) . Immullomicroscopy suggests that 
the antigen is meianosomal [11). However, it is not c1car if this 
antigen fulfills the expected cri teria for an authentic matrix protein, 
namely insolubility in non-ionic detergent, nor would an authentic 
melanosomal matrix prote in be restricted to mali gnant melanoma 
because no r111al111elanocytcs engaged in the synthesis of eumelanin 
contain melanosomes with a matrix. Alternatively, the HMSA-l 
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Figure 5_ Biosynthetic studies of matrix antigens. A, B16 cells were pulsed 
with [3SS] methionine/cysteine for 15 min in the presence of the following 
concentration of glycosylation inhibitors: (0) no additions, (T) tunicamycin 
(20 Jlg/ml) , (S) swainsonjne (1J1g/ ml) , and (0) deoxymannojirimycin (1 
mM) . Labeling and subsequent immunoprecipitation were carried out as 
described [3]. B, B16 cells were labeled for 4 h with [3SS] methionine/cys-
teine (Iall es 0) or labeling was fo ll owed by a 4-h chase with non-radioactive 
medium (Ialles 4) . Immunopreciptation and SOS-PAGE with normal rabbit 
serum (NRS) or aMX serum was carried out as described [1 3] with the 
addition of 0.1 % SOS to extraction and washing buffers. 
antibody may recognize an epitope (glycosylation dependent ?) that 
differs between melanoma and normal melanocytes. The relation-
ship of our antigen to those recognized by HMSA-l is uncl ear. 
Maeda and colleagues [23] have described another monoclonal 
antibody, HMSA-2, which reacts with melanocytes and dysplastic 
melanocytic nevi. This antibody precipitated antigens of identical 
Mr to those we describe, 94 and 53 kDa, from the culture medium 
of melanoma cells, but the authors could detect no cell-associated 
antigen by immunoprecipitation. However, immunoelectronmi-
croscopy revealed a pattern essentially identical to the one we ob-
served using aMX serum. We believe that the antigens described by 
th ese authors are identica l to the matrix glycoproteins we have 
identified. The relative insolubil ity of the 53-kDa protein in buffers 
lacking SDS cou ld well explain the inability of the HMSA-2 anti-
body to immunoprecipitate its antigens from Triton-soluble cell 
extracts. If, indeed, th e antigens recognized by HMSA-2, a I1'IOtJoclo-
nat antibody that should recognize a single epitope, are identical to 
th e antigens we have described, it lends further support to a 
precursor-product relationship between the 94- and 53-kDa spe-
cies. Although we find that the majority of matrix antigen is cell 
associated, in keeping with the resu lts of Maeda et at [22] we have 
also found a low but reproducible level of the 94-kDa protein se-
creted into the cu lture medium (Orlow Sj, unpublished results). 
W e cou ld not confirm th e identity of the two proteins however, 
because in our hands th e epitope recognized by HMSA-2 does not 
survive immunoblotting, nor does HMSA-2 recognize an antigen in 
murine melanocytes or melanoma cells. 
The identification of a component of the melanosomal matrix 
will fac ilitate the direct testing of current hypotheses for melano-
somal biogenesis. Molecular cloning of the eDNA encoding the 
matrix protein wi ll shed further light on its structure and allow a 
comparative study of the signa ls that direct the subcellular traffick-
ing of the melanosomalmatrix and th e proteins of the melanosomal 
membrane . 
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